Eli Lilly's Q3 beats on top and bottom line

Wednesday, 23 Oct 2013 | 7:17 AM ET

We had strong revenue growth of six-percent, and three-percent of that growth was volume driven, says Derica Rice, Eli Lilly CFO, breaking down his company's Q3 results and discussing several products the drugmaker has in the pipeline and growth areas in their animal health business, which grew at eleven percent.